Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
S
STMM
vs
S&P 500
S&P 500
Over the past 12 months, STMM has underperformed S&P 500, delivering a return of 0% compared to S&P 500's +11% growth.
Stocks Performance
STMM vs S&P 500
Performance Gap
STMM vs S&P 500
Performance By Year
STMM vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Stemcell Holdings Inc
Glance View
Stemcell Holdings, Inc. is a holding company, which through its subsidiary, Stemcell Co., Ltd., is engaged in the regenerative medicine-related business. The company is headquartered in Minato-Ku, Tokyo-To. The company went IPO on 2018-04-13. The firm provides two options for stem cell regenerative therapy: autologous adipose derived mesenchymal stem cells (ADMSC) and natural killer cells (NK). The firm provides coordination services to facilitate its stem cell culturing business. Its coordination services include the introduction of patients to clinics, arranging patients’ schedules, and translating between patients and clinics. The firm offers Internet marketing services by providing search engine optimization for clinics. The company also offers property and equipment rental services. The firm operates through its wholly owned subsidiary, Stemcell Co., Ltd.